超声造影诊断胆囊癌的表现特征分析

doi:10.3969/j.issn.1672-5069.2018.04.046

Abstract

Zeng Hongying, Li Jinlian. Feature of gallbladder carcinoma by contrast enhanced ultrasonography[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 645-646.

[1] 张潇月,唐少珊. 超声造影鉴别诊断胆囊良恶性病变Meta分析. 中国医学影像技术,2015,31(9):1340-1343.
[2] 龚瑞,韩蕾. CEUS在胆囊息肉样病变鉴别诊断中的应用探讨. 中国疗养医学,2017,26(3):276-278.
[3] 钟昕,廖锦堂,龙湘党,等. 超声造影在肝外胆管癌诊断中的应用. 中国医学影像技术,2016,32(5):745-748.
[4] 李拓. 肝外胆管癌超声造影和增强MRI影像学特征及诊断价值比较. 中国CT和MRI杂志,2017,15(6):76-79.
[5] 杨瑜婧, 仝林虎. 胆囊癌组织淋巴管标记物D2-40和LYVE-1表达的临床意义. 实用肝脏病杂志,2016,19(6):742-744.
[6] Wu Q,Yan W,Yi L,et al.Diagnostic value of contrast-enhanced ultrasound in solid thyroid nodules with and without enhancement. Endocrine,2016,53(2):480-488.
[7] 栗雯霏,栗建辉,张彤迪. 超声造影在胆囊疾病中的诊断作用. 中国医疗设备,2017,32(4):114-117.
[8] 王威,夏辉,李兵.不同造影剂剂量行ERCP检查对胆道梗阻患者肝功能指标的影响及疾病预后分析. 实用肝脏病杂志,2017,20(5):580-583.
[9] 李春,陈莉,吕娅萍,等. 超声造影在胆囊良恶性肿瘤鉴别诊断中的应用价值. 南昌大学学报(医学版),2016,56(5):52-56.
[10] 刘建勇,周永和,李嘉,等. 原发性肝癌病理分化程度与超声造影表现的关系. 天津医药,2015,43(8):925-928.
[11] 刘佳,李毓红,尹庭辉,等. 肝脏超声造影、增强CT及增强MRI检查肝脏局灶性病变的安全性及耐受性比较. 器官移植,2016,7(3):219-221.
[12] Yaylak F,Deger A,Bayhan Z,et al.Histopathological gallbladder morphometric measurements in geriatric patients with symptomatic chronic cholecystitis. Irish J Med Sci,2015,185(4):871-876.
[13] 唐力,李建卫,吴松松,等. 超声造影与增强CT鉴别诊断肾脏囊性肿瘤良恶性的对比研究. 福建医药杂志,2017,39(3):130-132.
[14] Pēteris P,Maija R,Ilze S,et al.Diagnostic value of contrast-enhanced ultrasound evaluation of malignant and benign solitary thyroid nodules. Proc Latvian Acad Sci,2016,70(1):1-6.
[15] 甘玲,高云华,夏红梅,等. 超声造影鉴别心脏良、恶性肿瘤. 中国医学影像技术,2016,32(4):517-520.

Feature of gallbladder carcinoma by contrast enhanced ultrasonography

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[3]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[4]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[5]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[6]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[7]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[8]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[9]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[10]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[11]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[12]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
[13]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.
[14]	Zhang Junfei, Xu Heming, Song Haiyan, et al. Autoimmune hepatitis-primary biliary cholangitis overlap syndrome:poor diagnostic sensitivity of Paris' criteria in Chinese patients [J]. Journal of Practical Hepatology, 2019, 22(4): 537-540.
[15]	Liu Wenbo, Zhang Jianye, Bao Jiwu, et al. Application of indocyanine green-mediated near-infrared light detection technique in patients undergoing cholecystectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 573-576.